Amarin Corp Plcuk (AMRN) Other Working Capital Changes (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Other Working Capital Changes of $2.0 million for Q1 2026, down 84.34% year-over-year from $12.6 million in Q1 2025, and down 84.35% quarter-over-quarter from $12.6 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Other Working Capital Changes (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Other Working Capital Changes data on file, last reported at $2.0 million in Q1 2026.

  • Other Working Capital Changes for Q1 2026 came in at $2.0 million, down 84.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 77.25% YoY), and the FY2025 annual result was $5.2 million, up 1234.96% from the prior year.
  • Other Working Capital Changes fell to $2.0 million in Q1 2026 per AMRN's latest filing, from $12.6 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $24.3 million in Q2 2023 and troughed at -$34.2 million in Q3 2023.
  • A 5-year average of -$72375.0 and a median of $260000.0 in 2022 frame the typical range for Other Working Capital Changes.
  • On a YoY basis, Other Working Capital Changes climbed as much as 5338.42% in 2022 and fell as far as 905.78% in 2022.
  • A 5-year view of Other Working Capital Changes shows it stood at -$5.5 million in 2022, then surged by 145.79% to $2.5 million in 2023, then slumped by 1092.15% to -$24.8 million in 2024, then jumped by 150.79% to $12.6 million in 2025, then tumbled by 84.35% to $2.0 million in 2026.
  • Business Quant data shows AMRN's Other Working Capital Changes at $2.0 million in Q1 2026, $12.6 million in Q4 2025, and -$115000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.97 Mn
Mar 31, 2026 1.97 Mn
Dec 31, 2025 12.59 Mn
Dec 31, 2025 12.59 Mn
Sep 30, 2025 -115,000.00
Sep 30, 2025 -115,000.00
Jun 30, 2025 -12.59 Mn
Jun 30, 2025 -12.59 Mn
Mar 31, 2025 12.58 Mn
Mar 31, 2025 12.58 Mn
Sep 30, 2024 -24.78 Mn
Sep 30, 2024 -24.78 Mn
Jun 30, 2024 20.34 Mn
Jun 30, 2024 20.34 Mn
Mar 31, 2024 -401,000.00
Mar 31, 2024 -401,000.00
Dec 31, 2023 2.50 Mn
Dec 31, 2023 2.50 Mn
Sep 30, 2023 -34.19 Mn
Sep 30, 2023 -34.19 Mn